Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Insmed Inc. | 17 | 0 | 5 | 0 | €23.20 | €44.97 | 93.841% |
| Hutchison China MediTech Ltd ADR | 5 | 0 | 0 | 0 | €20.20 | €45.10 | 123.243% |
| AnaptysBio Inc | 9 | 1 | 4 | 0 | €23.40 | €45.21 | 93.205% |
| Rhythm Pharmaceuticals | 15 | 0 | 2 | 0 | €37.20 | €45.98 | 23.602% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| Pacira Pharmaceuticals | 18 | 0 | 3 | 0 | €27.40 | €47.53 | 73.460% |
| Fresenius Medical Care AG & Co KGaA ST | 5 | 0 | 0 | 0 | €42.01 | €48.50 | 15.449% |
| Staar Surgical Co. | 12 | 1 | 1 | 0 | €39.51 | €49.33 | 24.847% |
| Bayer AG | 15 | 1 | 1 | 0 | €28.68 | €50.00 | 74.338% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 1 | 0 | €40.00 | €50.00 | 25.000% |
| Halozyme Therapeutics Inc. | 14 | 0 | 3 | 0 | €42.35 | €50.33 | 18.849% |
| Arrowhead Pharmaceuticals Inc. | 14 | 2 | 2 | 0 | €22.88 | €52.03 | 127.382% |
| Radnet Inc. | 9 | 3 | 2 | 0 | €54.00 | €54.58 | 1.075% |
| Catalent Inc. | 2 | 0 | 0 | 0 | €51.20 | €55.00 | 7.422% |
| Celldex Therapeutics | 11 | 1 | 2 | 0 | €37.00 | €56.62 | 53.019% |
| Drägerwerk AG & Co. KGaA VZO | 3 | 0 | 0 | 0 | €50.20 | €57.50 | 14.542% |
| Intellia Therapeutics Inc | 13 | 1 | 1 | 1 | €24.04 | €60.55 | 151.889% |
| Galmed Pharmaceuticals Ltd. | 7 | 0 | 3 | 0 | €0.35 | €63.93 | 18377.168% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €69.40 | €65.00 | -6.340% |
| Axonics Modulation Technologies Inc | 9 | 0 | 0 | 0 | €62.00 | €66.53 | 7.305% |
| LivaNova plc | 9 | 0 | 3 | 0 | €56.00 | €66.59 | 18.916% |
| XOMA Corp. | 6 | 0 | 3 | 0 | €22.40 | €68.78 | 207.050% |
| Lemaitre Vascular Inc | 2 | 0 | 1 | 0 | €71.00 | €69.00 | -2.817% |
| Apellis Pharmaceuticals | 3 | 0 | 0 | 0 | €38.22 | €70.00 | 83.150% |
| Boston Scientific | 47 | 0 | 10 | 0 | €69.00 | €73.22 | 6.120% |